Karzoon, A., Yerer, M. B., & Cumaoğlu, A. (2025). Empagliflozin demonstrates cytotoxicity and synergy with tamoxifen in ER-positive breast cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 398(1), 781-798. https://doi.org/10.1007/s00210-024-03316-z
Chicago-referens (17:e uppl.)Karzoon, Ahmad, Mükerrem Betül Yerer, och Ahmet Cumaoğlu. "Empagliflozin Demonstrates Cytotoxicity and Synergy with Tamoxifen in ER-positive Breast Cancer Cells." Naunyn-Schmiedeberg's Archives of Pharmacology 398, no. 1 (2025): 781-798. https://doi.org/10.1007/s00210-024-03316-z.
MLA-referens (9:e uppl.)Karzoon, Ahmad, et al. "Empagliflozin Demonstrates Cytotoxicity and Synergy with Tamoxifen in ER-positive Breast Cancer Cells." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 398, no. 1, 2025, pp. 781-798, https://doi.org/10.1007/s00210-024-03316-z.
